{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:42:09Z","timestamp":1789353729798,"version":"build-2803163510"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There is a compelling need for more effective vaccine adjuvants to augment induction of Ag-specific adaptive immune responses. Recent reports suggested the bacterial second messenger bis-(3\u2032\u20135\u2032)-cyclic-dimeric-guanosine monophosphate (c-di-GMP) acts as an innate immune system modulator. We recently incorporated a Vibrio cholerae diguanylate cyclase into an adenovirus vaccine, fostering production of c-di-GMP as well as proinflammatory responses in mice. In this study, we recombined a more potent diguanylate cyclase gene, VCA0848, into a nonreplicating adenovirus serotype 5 (AdVCA0848) that produces elevated amounts of c-di-GMP when expressed in mammalian cells in vivo. This novel platform further improved induction of type I IFN-\u03b2 and activation of innate and adaptive immune cells early after administration into mice as compared with control vectors. Coadministration of the extracellular protein OVA and the AdVCA0848 adjuvant significantly improved OVA-specific T cell responses as detected by IFN-\u03b3 and IL-2 ELISPOT, while also improving OVA-specific humoral B cell adaptive responses. In addition, we found that coadministration of AdVCA0848 with another adenovirus serotype 5 vector expressing the HIV-1\u2013derived Gag Ag or the Clostridium difficile\u2013derived toxin B resulted in significant inhibitory effects on the induction of Gag and toxin B\u2013specific adaptive immune responses. As a proof of principle, these data confirm that in vivo synthesis of c-di-GMP stimulates strong innate immune responses that correlate with enhanced adaptive immune responses to concomitantly administered extracellular Ag, which can be used as an adjuvant to heighten effective immune responses for protein-based vaccine platforms against microbial infections and cancers.<\/jats:p>","DOI":"10.4049\/jimmunol.1501272","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T03:14:35Z","timestamp":1453346075000},"page":"1741-1752","source":"Crossref","is-referenced-by-count":15,"title":["In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens"],"prefix":"10.1093","volume":"196","author":[{"given":"Fadel S","family":"Alyaqoub","sequence":"first","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Michigan State University , East Lansing, MI 48824"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser A","family":"Aldhamen","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Michigan State University , East Lansing, MI 48824"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7213-0953","authenticated-orcid":false,"given":"Benjamin J","family":"Koestler","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Michigan State University , East Lansing, MI 48824"},{"name":"BEACON Center for the Study of Evolution in Action, Michigan State University , East Lansing, MI 48824"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6369-4180","authenticated-orcid":false,"given":"Eric L","family":"Bruger","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Michigan State University , East Lansing, MI 48824"},{"name":"BEACON Center for the Study of Evolution in Action, Michigan State University , East Lansing, MI 48824"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey S","family":"Seregin","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Michigan State University , East Lansing, MI 48824"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Pereira-Hicks","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Michigan State University , East Lansing, MI 48824"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Godbehere","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Michigan State University , East Lansing, MI 48824"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Waters","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Michigan State University , East Lansing, MI 48824"},{"name":"BEACON Center for the Study of Evolution in Action, Michigan State University , East Lansing, MI 48824"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Amalfitano","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, Michigan State University , East Lansing, MI 48824"},{"name":"Department of Pediatrics, Michigan State University , East Lansing, MI 48824"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"key":"2025030702132362300_r1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coi.2012.03.008","article-title":"Adjuvants for human vaccines","volume":"24","author":"Alving","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"2025030702132362300_r2","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/jps.21498","article-title":"Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution","volume":"98","author":"Vessely","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"2025030702132362300_r3","doi-asserted-by":"crossref","first-page":"93rv2","DOI":"10.1126\/scitranslmed.3002302","article-title":"Assessing the safety of adjuvanted vaccines","volume":"3","author":"Ahmed","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"2025030702132362300_r4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1128\/JB.06695-11","article-title":"Cyclic dimeric GMP-mediated decisions in surface-grown Vibrio parahaemolyticus: a different kind of motile-to-sessile transition","volume":"194","author":"Gomelsky","year":"2012","journal-title":"J. Bacteriol."},{"key":"2025030702132362300_r5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/pro.2093","article-title":"Sensing the messenger: the diverse ways that bacteria signal through c-di-GMP","volume":"21","author":"Krasteva","year":"2012","journal-title":"Protein Sci."},{"key":"2025030702132362300_r6","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1073\/pnas.1003738107","article-title":"Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis","volume":"107","author":"Jones","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030702132362300_r7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/ni.2460","article-title":"The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response","volume":"13","author":"Parvatiyar","year":"2012","journal-title":"Nat. Immunol."},{"key":"2025030702132362300_r8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni.2491","article-title":"STING and the innate immune response to nucleic acids in the cytosol","volume":"14","author":"Burdette","year":"2013","journal-title":"Nat. Immunol."},{"key":"2025030702132362300_r9","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1084\/jem.20082874","article-title":"A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP","volume":"206","author":"McWhirter","year":"2009","journal-title":"J. Exp. Med."},{"key":"2025030702132362300_r10","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1128\/IAI.01762-06","article-title":"Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia","volume":"75","author":"Karaolis","year":"2007","journal-title":"Infect. Immun."},{"key":"2025030702132362300_r11","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1128\/AAC.49.8.3109-3113.2005","article-title":"3\u2032,5\u2032-cyclic diguanylic acid reduces the virulence of biofilm-forming Staphylococcus aureus strains in a mouse model of mastitis infection","volume":"49","author":"Brouillette","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"2025030702132362300_r12","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2009.04.053","article-title":"c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection","volume":"27","author":"Hu","year":"2009","journal-title":"Vaccine"},{"key":"2025030702132362300_r13","doi-asserted-by":"crossref","first-page":"e109778","DOI":"10.1371\/journal.pone.0109778","article-title":"c-di-GMP enhances protective innate immunity in a murine model of pertussis","volume":"9","author":"Elahi","year":"2014","journal-title":"PLoS One"},{"key":"2025030702132362300_r14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bbrc.2009.07.061","article-title":"3\u2032,5\u2032-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection","volume":"387","author":"Yan","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025030702132362300_r15","doi-asserted-by":"crossref","first-page":"e26973","DOI":"10.1371\/journal.pone.0026973","article-title":"Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP","volume":"6","author":"Pedersen","year":"2011","journal-title":"PLoS One"},{"key":"2025030702132362300_r16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/irv.12056","article-title":"A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine","volume":"7","author":"Svindland","year":"2013","journal-title":"Influenza Other Respi. Viruses"},{"key":"2025030702132362300_r17","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.4049\/jimmunol.1301419","article-title":"Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses","volume":"191","author":"Huang","year":"2013","journal-title":"J. Immunol."},{"key":"2025030702132362300_r18","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.1303258","article-title":"Activation of the STING adaptor attenuates experimental autoimmune encephalitis","volume":"192","author":"Lemos","year":"2014","journal-title":"J. Immunol."},{"key":"2025030702132362300_r19","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4049\/jimmunol.178.4.2171","article-title":"Bacterial c-di-GMP is an immunostimulatory molecule","volume":"178","author":"Karaolis","year":"2007","journal-title":"J. Immunol."},{"key":"2025030702132362300_r20","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3382\/ps.2013-03143","article-title":"Effect of 3\u2032,5\u2032-cyclic diguanylic acid in a broiler Clostridium perfringens infection model","volume":"92","author":"Fatima","year":"2013","journal-title":"Poult. Sci."},{"key":"2025030702132362300_r21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2014.04.004","article-title":"A new adjuvant delivery system \u2018cyclic di-GMP\/YSK05 liposome\u2019 for cancer immunotherapy","volume":"184","author":"Miyabe","year":"2014","journal-title":"J. Control. Release"},{"key":"2025030702132362300_r22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/2326-6066.CIR-13-0123","article-title":"STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer","volume":"2","author":"Chandra","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"2025030702132362300_r23","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/2326-6066.CIR-14-0099","article-title":"STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment","volume":"2","author":"Ohkuri","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"2025030702132362300_r24","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1128\/JB.00564-08","article-title":"Identification and characterization of cyclic diguanylate signaling systems controlling rugosity in Vibrio cholerae","volume":"190","author":"Beyhan","year":"2008","journal-title":"J. Bacteriol."},{"key":"2025030702132362300_r25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2958.2006.05106.x","article-title":"Cyclic-diGMP signal transduction systems in Vibrio cholerae: modulation of rugosity and biofilm formation","volume":"60","author":"Lim","year":"2006","journal-title":"Mol. Microbiol."},{"key":"2025030702132362300_r26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1365-2958.2006.05568.x","article-title":"Smooth to rugose phase variation in Vibrio cholerae can be mediated by a single nucleotide change that targets c-di-GMP signalling pathway","volume":"63","author":"Beyhan","year":"2007","journal-title":"Mol. Microbiol."},{"key":"2025030702132362300_r27","doi-asserted-by":"crossref","first-page":"e1002719","DOI":"10.1371\/journal.ppat.1002719","article-title":"Cellular levels and binding of c-di-GMP control subcellular localization and activity of the Vibrio cholerae transcriptional regulator VpsT","volume":"8","author":"Shikuma","year":"2012","journal-title":"PLoS Pathog."},{"key":"2025030702132362300_r28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1462-2920.2004.00633.x","article-title":"Bacterial signal transduction network in a genomic perspective","volume":"6","author":"Galperin","year":"2004","journal-title":"Environ. Microbiol."},{"key":"2025030702132362300_r29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2180-14-22","article-title":"The Vibrio cholerae diguanylate cyclase VCA0965 has an AGDEF active site and synthesizes cyclic di-GMP","volume":"14","author":"Hunter","year":"2014","journal-title":"BMC Microbiol."},{"key":"2025030702132362300_r30","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/CVI.00471-14","article-title":"Stimulation of innate immunity by in vivo cyclic di-GMP synthesis using adenovirus","volume":"21","author":"Koestler","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"2025030702132362300_r31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.1002105","article-title":"Expression of the SLAM family of receptors adapter EAT-2 as a novel strategy for enhancing beneficial immune responses to vaccine antigens","volume":"186","author":"Aldhamen","year":"2011","journal-title":"J. Immunol."},{"key":"2025030702132362300_r32","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1182\/blood-2010-03-276949","article-title":"Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo","volume":"116","author":"Seregin","year":"2010","journal-title":"Blood"},{"key":"2025030702132362300_r33","doi-asserted-by":"crossref","first-page":"e9579","DOI":"10.1371\/journal.pone.0009579","article-title":"A new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic target","volume":"5","author":"Appledorn","year":"2010","journal-title":"PLoS One"},{"key":"2025030702132362300_r34","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.vaccine.2011.12.064","article-title":"Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice","volume":"30","author":"Seregin","year":"2012","journal-title":"Vaccine"},{"key":"2025030702132362300_r35","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1093\/nar\/18.13.4004","article-title":"Nucleotide sequence of Clostridium difficile toxin B gene","volume":"18","author":"Barroso","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"2025030702132362300_r36","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1128\/IAI.66.5.2018-2025.1998","article-title":"Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection","volume":"66","author":"Kink","year":"1998","journal-title":"Infect. Immun."},{"key":"2025030702132362300_r37","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4049\/jimmunol.1200736","article-title":"Vaccines expressing the innate immune modulator EAT-2 elicit potent effector memory T lymphocyte responses despite pre-existing vaccine immunity","volume":"189","author":"Aldhamen","year":"2012","journal-title":"J. Immunol."},{"key":"2025030702132362300_r38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mt.2008.297","article-title":"Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy","volume":"17","author":"Seregin","year":"2009","journal-title":"Mol. Ther."},{"key":"2025030702132362300_r39","doi-asserted-by":"crossref","first-page":"12746","DOI":"10.1073\/pnas.1115663109","article-title":"Quantification of high-specificity cyclic diguanylate signaling","volume":"109","author":"Massie","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030702132362300_r40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/CVI.00341-10","article-title":"Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated responses against HIV antigens despite preexisting Ad5 immunity","volume":"18","author":"Appledorn","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"2025030702132362300_r41","doi-asserted-by":"crossref","first-page":"e46959","DOI":"10.1371\/journal.pone.0046959","article-title":"Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses","volume":"7","author":"Ahl\u00e9n","year":"2012","journal-title":"PLoS One"},{"key":"2025030702132362300_r42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molimm.2014.10.020","article-title":"Immune response profile elicited by the model antigen ovalbumin expressed in fusion with the bacterial OprI lipoprotein","volume":"64","author":"Basto","year":"2015","journal-title":"Mol. Immunol."},{"key":"2025030702132362300_r43","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/CVI.00166-08","article-title":"Primary CD8+ T-cell response to soluble ovalbumin is improved by chloroquine treatment in vivo","volume":"15","author":"Garulli","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"2025030702132362300_r44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imlet.2008.11.003","article-title":"A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses","volume":"122","author":"Gabitzsch","year":"2009","journal-title":"Immunol. Lett."},{"key":"2025030702132362300_r45","doi-asserted-by":"crossref","first-page":"e24147","DOI":"10.1371\/journal.pone.0024147","article-title":"Vaccine platforms combining circumsporozoite protein and potent immune modulators, rEA or EAT-2, paradoxically result in opposing immune responses","volume":"6","author":"Schuldt","year":"2011","journal-title":"PLoS One"},{"key":"2025030702132362300_r46","doi-asserted-by":"crossref","first-page":"e1003001","DOI":"10.1371\/journal.ppat.1003001","article-title":"Vaccines: from empirical development to rational design","volume":"8","author":"Rueckert","year":"2012","journal-title":"PLoS Pathog."},{"key":"2025030702132362300_r47","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"2025030702132362300_r48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature07710","article-title":"AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA","volume":"458","author":"Fernandes-Alnemri","year":"2009","journal-title":"Nature"},{"key":"2025030702132362300_r49","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4049\/jimmunol.1301812","article-title":"MPYS\/STING-mediated TNF-\u03b1, not type I IFN, is essential for the mucosal adjuvant activity of (3\u2032-5\u2032)-cyclic-di-guanosine-monophosphate in vivo","volume":"192","author":"Blaauboer","year":"2014","journal-title":"J. Immunol."},{"key":"2025030702132362300_r50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7554\/eLife.06670","article-title":"The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo","volume":"4","author":"Blaauboer","year":"2015","journal-title":"eLife"},{"key":"2025030702132362300_r51","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"2025030702132362300_r52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature12640","article-title":"Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP","volume":"503","author":"Ablasser","year":"2013","journal-title":"Nature"},{"key":"2025030702132362300_r53","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","article-title":"Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol. Cell"},{"key":"2025030702132362300_r54","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1244040","article-title":"Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects","volume":"341","author":"Li","year":"2013","journal-title":"Science"},{"key":"2025030702132362300_r55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1126\/science.1240933","article-title":"Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses","volume":"341","author":"Gao","year":"2013","journal-title":"Science"},{"key":"2025030702132362300_r56","doi-asserted-by":"crossref","first-page":"e110150","DOI":"10.1371\/journal.pone.0110150","article-title":"Cyclic GMP-AMP displays mucosal adjuvant activity in mice","volume":"9","author":"\u0160krnjug","year":"2014","journal-title":"PLoS One"},{"key":"2025030702132362300_r57","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1128\/JVI.76.4.1559-1568.2002","article-title":"Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10","volume":"76","author":"Tibbles","year":"2002","journal-title":"J. Virol."},{"key":"2025030702132362300_r58","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.1187996","article-title":"The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K","volume":"329","author":"Verdino","year":"2010","journal-title":"Science"},{"key":"2025030702132362300_r59","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.181.3.2134","article-title":"Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo","volume":"181","author":"Appledorn","year":"2008","journal-title":"J. Immunol."},{"key":"2025030702132362300_r60","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/JVI.02192-06","article-title":"Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways","volume":"81","author":"Zhu","year":"2007","journal-title":"J. Virol."},{"key":"2025030702132362300_r61","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000207194","article-title":"TRIF, and TRIF-interacting TLRs differentially modulate several adenovirus vector-induced immune responses","volume":"1","author":"Appledorn","year":"2009","journal-title":"J. Innate Immun."},{"key":"2025030702132362300_r62","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature06537","article-title":"TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines","volume":"451","author":"Ishii","year":"2008","journal-title":"Nature"},{"key":"2025030702132362300_r63","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J. Clin. Invest."},{"key":"2025030702132362300_r64","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/eji.200636026","article-title":"From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation","volume":"36","author":"Soumelis","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"2025030702132362300_r65","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2249.2005.02700.x","article-title":"Mature dendritic cells differentiated in the presence of interferon-beta and interleukin-3 prime functional antigen-specific CD8 T cells","volume":"139","author":"Renneson","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"2025030702132362300_r66","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2567.2011.03412.x","article-title":"Regulation of effector and memory T-cell functions by type I interferon","volume":"132","author":"Huber","year":"2011","journal-title":"Immunology"},{"key":"2025030702132362300_r67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cellimm.2012.07.006","article-title":"Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities","volume":"278","author":"Gray","year":"2012","journal-title":"Cell. Immunol."},{"key":"2025030702132362300_r68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbrc.2005.01.093","article-title":"3\u2032,5\u2032-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation","volume":"329","author":"Karaolis","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025030702132362300_r69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14760584.2014.851606","article-title":"Tumor lysate-loaded biodegradable microparticles as cancer vaccines","volume":"13","author":"Joshi","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"2025030702132362300_r70","doi-asserted-by":"crossref","first-page":"e1003861","DOI":"10.1371\/journal.ppat.1003861","article-title":"STING-dependent type I IFN production inhibits cell-mediated immunity to Listeria monocytogenes","volume":"10","author":"Archer","year":"2014","journal-title":"PLoS Pathog."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/196\/4\/1741\/62256786\/1501272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/196\/4\/1741\/62256786\/1501272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T02:22:33Z","timestamp":1741314153000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/196\/4\/1741\/7961688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,2,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1501272","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,2]]},"published":{"date-parts":[[2016,2]]}}}